Recent Insights from the Avalere Center for Payment & Delivery Innovation

  • This page as PDF

Summary

The Avalere Center for Payment & Delivery Innovation is a leading voice in helping organizations succeed in a value-based healthcare environment.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

The Avalere Center for Payment & Delivery Innovation is a leading voice in helping organizations succeed in a value-based healthcare environment. Quoted regularly in trade press and national media, here’s a sample of what Josh Seidman, head of The Center, has shared:

    When CMS opened up data on reimbursement for 880,000 Medicare providers last May, the deluge of analysis coming in 140-character increments was breathtaking. Read on from Health Affairs.
    Little debate exists that the U.S. healthcare system needs to transition from turnstile medicine to value-based care. The biggest challenges relate to how we get there. Read on from The Health Care Blog.
    Last summer, when health policy wonks inside and outside the Beltway were placing bets on when the new proposed rule for the Medicare Shared Savings Program would be released, we shared our take in Morning Consult. Read on.
    Hear an interview with Josh Seidman as he shares his take on the role of meaningful use and electronic health records to improve patient care. Listen in.
    Standing at the intersection of payment reform and the power of consumer data, what’s next for the role of reforms and data in powering clinical insight? Read on from The Health Care Blog.

For more information, contact Josh Seidman at JSeidman@avalere.com.

Webinar | A Closer Look at Patient Support On June 6 at 2 PM ET, Avalere experts will explore how potential implications of the Inflation Reduction Act (IRA)’s out-of-pocket cap, in addition to other key regulatory and policy activities shaping benefit design and patient cost-share (e.g., EHB), could impact patient commercial and foundation assistance. Learn More
Register

Sign up to receive more insights about
Please enter your email address to be notified when new insights are published.

Back To Top